Winners!
Congratulations to the UIC Innovator of the Year, Innovator of the Year, and the College of Medicine's Distinguished Researchers and Rising Stars
»Details and list of winners
Our research goals are broad and ambitious, as are the needs and hopes of our patients.
We aim to advance treatment now, and health in the future, by pursuing both fundamental insights and their application to the practice of medicine. Investigators across the College of Medicine are doing cutting-edge research in clinical medicine, in basic biomedical science, and in the translation of basic findings into clinical practice and societal health. Focus areas include cancer, women's health, neurosciences, cardiac and vascular medicine, infectious disease, and obesity and diabetes.
NOTABLE RESEARCH HIGHLIGHTS:
A pair of new assays that can detect key Alzheimer’s molecules in human brain tissues and in lab mice may offer a quick way to identify new effective drug treatments.The assays may also prove useful in identifying people at increased risk for the disease, which would help determine who should get a preventive drug should one be discovered, says Mary Jo LaDu, associate professor of anatomy and cell biology at the University of Illinois at Chicago College of Medicine, who is principal investigator of the study.
» Full story: New Alzheimer’s Chemical Test May Identify People at Risk or Point to New Drugs
Islet transplant may slow progression of atherosclerosis. Minimally invasive islet transplantation for patients with type 1 diabetes achieves insulin independence and reverses the progression of atherosclerosis in the first few years after transplant, according to a University of Illinois at Chicago study. The research is published in the February issue of the journal Diabetes Care and is available online.
» Full story: Islet transplant may slow progression of atherosclerosis
Researchers at the University of Illinois at Chicago College of Medicine have been awarded more than $11.7 million to study the pathology of severe lung injury. The study, part of a multi-pronged investigation into acute lung injury, or ALI, is funded by the National Heart, Lung and Blood Institute, one of the National Institutes of Health.
»Full story: $12 Million Funds Interdisciplinary Investigation of Acute Lung Injury